SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the WiSE CRT System for the treatment of heart failure.

he...

• Lead gene therapy candidate significantly reduced seizures and reversed early mortality in preclinical model of Dravet Syndrome

• Company aims to maximize the potential of genomics-driven precision medicine by overcoming key limitations of viral gene therapy

• Financing syndicate comprised of pr...

Company Also Expands Board of Directors and Executive Management Team with Key Appointments

San Francisco – June 13, 2019 – BlackThorn Therapeutics, a clinical-stage, neurobehavioral health company pioneering next-generation artificial intelligence (AI) technologies to advance targeted therapeutics, today...

• At record levels of 415 parts per million (ppm), the Earth’s atmosphere contains one trillion tons (one teraton) more carbon dioxide today than it did prior to the Industrial Revolution.

• Increasing the carbon levels in agricultural soils from today’s levels of approximately 1% back to native leve...

This Boston-based agricultural technology start-up is creating seed treatments that optimize the health of a plant in order to increase its yield. The aim is to use natural microbiology and tech to improve sustainability, profits for growers and, of course, consumer health. Currently, the company's seed t...

Vividion Therapeutics snagged $82 million in an oversubscribed Series B funding round to bolster its cash holdings that will be used to advance the San Diego-based company’s lead programs into the clinic and broaden the early-stage pipeline of therapeutics against previously intractable drug targets.

The l...

EMERYVILLE, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), an immuno-oncology company developing tumor-specific cancer immunotherapies to fight multiple cancer types, today announced that following feedback from the U.S. Food and Drug Administration (FDA) the SLATE Pha...

Phase 1 results and new translational data supporting the development of BTRX-335140 for neurobehavioral disorders presented at the Kappa Therapeutics 2019 Conference

San Francisco – April 1, 2019 – BlackThorn Therapeutics, a neurobehavioral health company leveraging its proprietary computational psychiatr...

BOSTON--(BUSINESS WIRE)--Indigo Agriculture, a company dedicated to harnessing nature to help farmers sustainably feed the planet, and Anheuser-Busch, the country’s leading brewer, have announced a partnership focused on sustainable rice production. Indigo has committed to delivering 2.2 million bushels o...

Beam Therapeutics made a splash last year when it launched with $87 million to develop medicines that use a more precise form of CRISPR editing. Beam’s promise of CRISPR-based therapeutics that swap out specific bases or “letters” in the genome—something the current generation of CRISPR-based drugs can’t...